Navigation Links
Nektar Therapeutics Reports Third Quarter 2010 Financial Results
Date:11/4/2010

, clinical outcomes, competitive factors, or delay or failure in ultimately obtaining regulatory approval in one or more important markets; (iii) scientific discovery of new medical breakthroughs is an inherently uncertain process and the future success of the application of Nektar's technology platforms to potential new drug candidates is therefore very uncertain and unpredictable and one or more research and development programs could fail; (iv) Nektar's patent applications for its proprietary or partner product candidates may not issue, patents that have issued may not be enforceable, or additional intellectual property licenses from third parties may be required in the future; (v) the outcome of any future intellectual property or other litigation related to Nektar's proprietary product candidates or complex commercial agreements; (vi) if Nektar is unable to establish and maintain collaboration partnerships on attractive commercial terms (such as for NKTR-102), our business, results of operations and financial condition could suffer; and (vii) certain other important risks and uncertainties set forth in Nektar's Quarterly Report on Form 10-Q for the quarter ended June 30, 2010 filed with the SEC on July 28, 2010, the Current Report on Form 8-K filed with the SEC today, and the Quarterly Report on Form 10-Q for the quarter ended September 30, 2010 to be filed with the SEC on or about November 4, 2010.  Actual results could differ materially from the forward-looking statements contained in this press release.  Nektar undertakes no obligation to update forward-looking statements, whether as a result of new information, future events or otherwise.

Nektar Investor Inquiries:Jennifer Ruddock/Nektar Therapeutics(650) 631-4954Susan Noonan/SA Noonan Communications, LLC(212) 966-3650Nektar Media Inquiries: Karen Bergman/BCC Partners(650) 575-1509 Michelle Corral/BCC Partners(415) 794-866
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Nektar to Announce Financial Results for the Third Quarter of 2010 on Thursday, November 4, 2010, After Close of U.S.-Based Financial Markets
2. Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
3. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
4. Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
5. Nektar Therapeutics Reports Second Quarter 2009 Financial Results
6. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
7. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
8. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
9. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
10. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
11. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... Sept. 2, 2014 /PRNewswire-iReach/ -- Ortho Development® Corporation (ODEV) ... Stem, the latest addition to its growing hip ... intended for use in total hip arthroplasty and ... Alpine was developed based ... ODEV,s engineers worked closely with a select team ...
(Date:9/2/2014)... ,S-HERTOGENBOSCH, the Netherlands , Sept. 2, ... expanded its North American operations through its subsidiary HealthLink ... fulfillment and order to cash services for medical device ... our global ERP platform. Building on the ... in Europe with customer service, ...
(Date:9/2/2014)... -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, ... Drew Young has joined the company as Senior ... will be responsible for leading the strategic direction of ... Bringing more than 20 years of experience ... pharmaceutical and biotech companies, Mr. Young comes to EMD ...
Breaking Medicine Technology:Ortho Development Receives FDA Clearance for Alpine Hip Stem 2HealthLink Europe opens North American medical warehouse operation 2EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology 2EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology 3EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology 4
... CAMBRIDGE, Mass., Oct. 27 Novartis announced today that ... million over the next five years to expand its ... Mass.   "Novartis was the first global ... just a few years ago.  It has achieved prominence ...
... According to Millennium Research Group (MRG), the global ... arthroscope market generated over $30 million in 2010. ... to decreasing scope prices and greater market penetration ... unfavorable economic conditions, manufacturers are being forced to ...
Cached Medicine Technology:Novartis to Expand Global Research Headquarters in Cambridge, MA 2Novartis to Expand Global Research Headquarters in Cambridge, MA 3Novartis to Expand Global Research Headquarters in Cambridge, MA 4Despite Rising Procedure Volumes, the $30 Million European Arthroscope Market Experienced Nominal Growth in 2010 2Despite Rising Procedure Volumes, the $30 Million European Arthroscope Market Experienced Nominal Growth in 2010 3
(Date:9/2/2014)... TCG, a leading government technology strategy and IT consultancy, has ... companies in America for the seventh year in a row, ... 2013, 2012, 2011, 2010, 2009, 2008, and the Inc. 500 ... to 2013, ranking the company at position 3,708 on the ... 635 spots from 2013! More information is on TCG's ...
(Date:9/2/2014)... The Wm. Jennings Bryan Dorn Veterans Affairs Medical Center will ... Veterans and their families on September 24. , “Staff ... with valuable healthcare and benefit information,” said Medical Center Director ... where we can gather important input directly from Veterans to ... held 4:45 p.m. to 5:45 p.m. in the main lobby ...
(Date:9/2/2014)... Among women diagnosed with early-stage breast cancer in California, ... 1998 and 2011, although this procedure was not associated ... plus radiation, according to a study in the September ... find that surgery for the removal of one breast ... the other options examined in the study. , Randomized ...
(Date:9/2/2014)... Medex Analytic Services is delighted to ... Coral Springs, Fla. due to their greater than forecasted ... for the 2014 year by distinguishing Medex in the ... a higher level of service and professionalism in the ... the industry has responded.” , The location of the ...
(Date:9/2/2014)... Two new studies further confirm the health benefits of ... have a lower risk of ear, throat and sinus ... a similar trend when it comes to allergies. ... the immediate newborn period," said Dr. Jennifer Wu, an ... She was not involved in the new studies. ...
Breaking Medicine News(10 mins):Health News:TCG One of the Fastest-Growing Companies in America – for the Eighth Time! 2Health News:Increase seen in use of double mastectomy 2Health News:Increase seen in use of double mastectomy 3Health News:Medex Analytic Services Announces New Location for Corporate Headquarters 2Health News:More Evidence Breast-Feeding Lowers Child's Risk of Infections, Allergies 2
... The American Society of Anesthesiologists, Action vs. RhetoricCORONA DEL ... doesn,t seem like very fair odds. Yet, that,s exactly ... Dr. Barry Friedberg, set the stage for last week ... (ASA) March 9 press release in which they claimed ...
... ... Beach, CA. (PRWEB) March 19, 2009 -- Secova, a leading provider ... a summary of the healthcare provisions in the $787 billion stimulus ... Obama’s new administration, Secova is working diligently to identify all possible ...
... services to group practices, multi-specialty clinics and community health centers, ... Associates. , ... Scottsdale, AZ (PRWEB) ... of medical transcription services to group practices, ...
... ALCMI,s founding organization, the Bonnie J. Addario Lung Cancer ... advertising campaign to raise $20 from one million people in ... CBS Outdoor and friends of the Foundation to raise awareness ... billboards in New York City, Los Angeles, Washington, D.C., San ...
... - Findings from the first in-depth study of patient ... with other acute care facilities without knowing it. ... meeting of the Society for Healthcare Epidemiology of America ... patients is directly transferred from one hospital to another, ...
... time to progress and cause irreversible damage, doctors say , , ... the sudden and tragic death Wednesday of actress Natasha Richardson, ... minor fall on a Canadian ski slope on Tuesday have ... been born into one of the most lauded acting families ...
Cached Medicine News:Health News:Dr. Barry Friedberg comments on David vs. Goliath: Who's Really in the Pursuit of Patient Safety & Satisfaction? 2Health News:Secova Reports Healthcare Provisions In The Stimulus Bill 2Health News:Secova Reports Healthcare Provisions In The Stimulus Bill 3Health News:MxSecure, Inc. Completes Custom Document Management Interface for Roanoke Neurological Associates 2Health News:MxSecure, Inc. Completes Custom Document Management Interface for Roanoke Neurological Associates 3Health News:Joan Gaeta Lung Cancer Foundation Donates $15,000 to Addario Lung Cancer Medical Institute (ALCMI) for Lung Cancer Research 2Health News:Joan Gaeta Lung Cancer Foundation Donates $15,000 to Addario Lung Cancer Medical Institute (ALCMI) for Lung Cancer Research 3Health News:Study finds extensive patient sharing among hospitals; could impact spread of infectious diseases 2Health News:Brain Hemorrhage Might Explain Natasha Richardson's Death 2Health News:Brain Hemorrhage Might Explain Natasha Richardson's Death 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: